Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "PPL"

3711 News Found

How a robust supply chain ensured Indian pharma industry’s triumph over COVID-19
Supply Chain | February 26, 2021

How a robust supply chain ensured Indian pharma industry’s triumph over COVID-19

The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges


LupinLife Launches ayurvedic energy supplement
News | February 12, 2021

LupinLife Launches ayurvedic energy supplement

Be One is a 100% Ayurvedic health and wellness supplement.


SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026
Digitisation | June 24, 2026

SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026

Bengaluru-based startup recognised for building autonomous AI agents for pharmaceutical and medtech commercial operations, joins select cohort of 40 startups in India-focused accelerator programme


Apexon partners with AWS to accelerate Agentic AI adoption in healthcare and life-sciences
Digitisation | June 24, 2026

Apexon partners with AWS to accelerate Agentic AI adoption in healthcare and life-sciences

Partnership combines Apexon's agentic AI platforms and cloud modernization tools with AWS infrastructure to accelerate AI deployment, clinical innovation, and digital transformation across healthcare and life sciences


FDA advisory panel backs Moderna flu vaccine candidate for older adults
News | June 23, 2026

FDA advisory panel backs Moderna flu vaccine candidate for older adults

The backing comes as influenza remains a persistent public health burden


FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
News | June 23, 2026

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average


Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
News | June 23, 2026

Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results

The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines


WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
News | June 23, 2026

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center

Clearing 19 biologics for Europe market


71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study
Healthcare | June 23, 2026

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study

Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable